Sur180 Therapeutics
Mcallen
About Sur180 Therapeutics
We are a women's owned startup focusing on new therapeutic approaches to gynecological conditions. Our primary focus is endometriosis. We approach endometriosis with a holistic view and our therapies focus on the stress system rather that on the reproductive system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $2.8M
- Last round: Grant (Jul 2025)
- Website: sur180therapeutics.com
- Phone: 9567141499
Industries & Categories
Biopharma
Social Profiles
Canonical: https://fsome.com/organization/sur180-therapeutics-46610 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.